Search filters

List of works by Corinne Faivre-Finn

103 Do treatment decisions made at lung cancer multi-disciplinary team meetings (MDTs) reflect the actual treatment given in practice?

article

103 Impact of integration of fused FDG-PET and CT information for GTV delineation

106 An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases (BM) to the QUARTZ Clinical Trial at the Christie

110 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part one, baseline characteristics, survival and QALYs

111 Quality of life after treatment for brain metastases: interim data from the MRC QUARTZ clinical trial. Part two, symptoms, quality of life and data completion

113 Cone beam computed tomography (CBCT) based adaptive radiotherapy for lung cancer? The Christie experience

113: Do standardised uptake values from PET-CT scans predict EGFR status of lung tumours?

article

117 CONVERT: Concurrent Once-Daily Versus Twice-Daily Radiotherapy - a phase III randomised controlled trial for patients with LS SCLC and good performance status

article by Corinne Faivre-Finn & S. Falk published January 2011 in Lung Cancer

118 Smoking habits in lung cancer patients and their carers and audit of smoking advice given

article

1260POUTCOMES OF ELDERLY PATIENTS (≥70 YO) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A MULTI-INSTITUTIONAL ANALYSIS

article

1282PBRAIN METASTASES (BM) IN PATIENTS WITH EGFR MUTATIONS – A REVIEW OF INCIDENCE AND OUTCOMES

article

135: Intra-fractional tumour motion and an isotropic margin: lung stereotactic ablative body radiotherapy treatment – practice evaluation

136 Electronic patient reported outcomes significantly improved toxicity data collection and were acceptable to both patients and clinicians in lung cancer radiotherapy outpatient clinics

article

140: Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) – a feasibility study

143 A review of changes in lung radiotherapy treatment techniques during the CONVERT trial

144 A comparison of pre-trial QA versus ongoing QA for the CONVERT trial

144: A single centre's experience of toxicity, compliance and survival in patients with stage III locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemo-radiotherapy (CCTRT)

article

146 One year on: early report of intensity modulated radiotherapy (IMRT) for locally advanced lung cancer at the Christie

150 Ninety-day mortality following radical radiotherapy for lung cancer

150: A re-audit of mortality rates after palliative radiotherapy for lung cancer from a single UK radiotherapy centre

152 The feasibility of conducting radiotherapy trials in patients with stage II–III non-small cell lung cancer (NSCLC) not eligible for chemotherapy and/or surgery: results of a clinical audit over an 18-month period

152 The impact of IMRT on the treatment of patients with N3M0 lung cancer at The Christie

154 Concurrent chemoradiotherapy (cCTRT) for locally-advanced, unresectable non-small cell lung cancer (LA-NSCLC): A national survey of current practice

155: Predictors of failure for PS2–3 patients undergoing hypo-fractionated radical radiotherapy for NSCLC – experience of a UK centre

156: Outcome for performance status 2–3 patients undergoing hypo-fractionated radical radiotherapy for NSCLC

157 Comparison of outcomes for early small cell lung cancer (SCLC) treated with surgery versus concurrent chemo radiation (CTRT)

article

157 Mortality rates after palliative radiotherapy for lung cancer from a single UK radiotherapy centre

157 Radical radiotherapy for NSCLC in the very elderly: Can failure to tolerate treatment be predicted?

159 Quality of life after treatment for brain metastases: An update on the QUARTZ trial – one year on from an interim data release

160 The largest single centre series using hypofractionated radical radiotherapy treatment for NSCLC (non-small cell lung cancer) in the very elderly

161 Acute toxicity of prophylactic cranial irradiation (PCI) in extensive stage small cell lung cancer (ES-SCLC): A prospective audit from a UK radiotherapy centre

article

161 Investigation of a patient reported outcome tool to assess radiotherapy-related toxicity in patients with lung cancer

article

161 Isotoxic radiotherapy for non-small cell lung cancer: is intensity modulated radiotherapy (IMRT) the answer?

162 Intensity modulated radiotherapy (IMRT) in locally advanced non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): Analysis of survival and toxicity outcomes

article

162 Quality of life after treatment for inoperable brain metastases from non-small cell lung cancer: An update on the Medical Research Council QUARTZ randomised clinical trial

163 REST: A randomised trial comparing prophylactic cranial irradiation (PCI) to PCI + thoracic radiotherapy in extensive stage small cell lung cancer (ES-SCLC)

164 Clinical characteristics and radiotherapy planning parameters as predictors of radiation-induced oesophageal toxicity following radical radiotherapy (rRT) for small cell (SCLC) and non-small cell lung cancer (NSCLC)

article

165 An investigation into the efficacy and toxicity of stereotactic ablative body radiotherapy for lung cancer at The Christie NHS Foundation Trust

article

165 Clinical characteristics and radiotherapy planning parameters as predictors of radiation-induced pulmonary toxicity following radical radiotherapy (rRT) for small cell (SCLC) and non-small cell lung cancer (NSCLC)

article

166 Audit on the characteristics of lung cancer patients who receive BSC (best supportive care)

article

166: REST – a Dutch/UK randomized phase III trial on the use of thoracic radiotherapy in extensive stage small-cell lung cancer

167 CONVERT: Concurrent ONce-daily VErsus twice-daily RadioTherapy. A phase III randomised controlled trial for patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

article by Corinne Faivre-Finn & S. Falk published January 2012 in Lung Cancer

167: Thoracic radiotherapy in extensive stage small cell lung cancer

article

168 Experiences of pre-trial quality assurance (QA) for the CONVERT trial. A multicentre randomised phase III trial for good performance status patients with limited stage small cell lung cancer

168 QUALITY OF LIFE OF PATIENTS RECEIVING STEROIDS AND OPTIMAL SUPPORTIVE CARE WITH OR WITHOUT WHOLE BRAIN RADIOTHERAPY IN THE TREATMENT OF INOPERABLE BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER: THE MRC QUARTZ RANDOMIZED TRIAL

scholarly article by R. Barton et al published September 2009 in Radiotherapy and Oncology

170 Lung ART: Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement

173 Assessing CT changes post stereotactic ablative body radiotherapy (SABR) using the criteria proposed by Senan et al

181 CONVERT – the challenges of opening a multi-centre radiotherapy trial in the UK

182 Do circulating tumour cell (CTC) counts correlate with tumour volume in limited disease small cell lung cancer (LD-SCLC)? An exploratory clinical study with survival outcomes

183: PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

184 Toxicities and compliance to treatment in locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemoradiotherapy (cCTRT) at the Christie NHS Foundation Trust

article

184: Quality assurance programme for the isotoxic intensity modulated radiotherapy feasibility study

185 CONVERT – a successful international collaboration between the UK NCRI, Groupe Français de Pneumo-Cancérologie, Spanish Lung Cancer Group, EORTC and NCI Canada

article

188 ADSCaN: a randomised phase II study of Accelerated, Dose escalated, Sequential, Chemo-radiotherapy in Non-Small Cell Lung Cancer

188: Quality of life after treatment for brain metastases: final demographic data from the QUARTZ trial

189: Lung ART: phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement

18F-Fludeoxyglucose PET/CT in SCLC: Analysis of the CONVERT Randomized Controlled Trial

scientific article published on 16 April 2019

190 Testing the feasibility of establishing a cohort of lung cancer patients to investigate recovery following radiotherapy with curative intent

190: LungTech stereotactic body radiotherapy (SBRT) of inoperable centrally located NSCLC: a phase II study in preparation for a randomised phase III trial

191 Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) – a feasibility study

193 PIT: a phase III trial of Prophylactic Irradiation of Tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

215 Isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC) – a feasibility study

216 PIT: A phase III trial of Prophylactic Irradiation of Tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

217 Lung ART: Phase III study comparing post-operative conformal radiotherapy to no post-operative radiotherapy in patients with completely resected non-small cell lung cancer and mediastinal N2 involvement

251 Radiotherapy

26 X-ray volumetric imaging (XVI) to quantitate the dosimetric impact of the uncertainties during radical radiotherapy (RT) of non small cell lung cancers

2IN EARLY AND LOCALLY ADVANCED DISEASE

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

scientific article

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

scientific article published on 20 February 2014

33IN ELDERLY AND CO-MORBID PATIENTS – RADIOTHERAPY

35 CONVERT-A multicentre randomised controlled NCRN trial comparing accelerated twice-daily and high dose once-daily thoracic radiotherapy in good performance status (PS), limited small-cell lung cancer (LD SCLC) treated concurrently with cisplatin a

article by Corinne Faivre-Finn et al published August 2007 in Lung Cancer

48 Radical management of inoperable stage III non-small cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN) – an analysis of patient eligibility and justification for treatment

55 Prophylactic radiotherapy to intervention sites in mesothelioma

69 PIT: A phase III trial of prophylactic irradiation of tracks in patients with malignant pleural mesothelioma following invasive chest wall intervention

78P AVAILABILITY OF EGFR MUTATION STATUS AT FIRST ONCOLOGY CONSULTATION FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER PATIENTS. A PILOT EXPERIENCE FROM THE CHRISTIE

article

89 Management of stage III non-small-cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN): an analysis of current practice

9070 POSTER Whole Brain Radiotherapy for Inoperable Brain Metastases From Non-small Cell Lung Cancer – Individual Versus Community Uncertainty

97 PIT: A Phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

98 A paradigm shift IMRT enables radical treatment in locally advanced lung cancer patients who would have been treated with palliative intent with 3D conformal radiotherapy (3D CRT)

A Higher Integral Heart Dose Is Associated With Lymphocytopenia in Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy

A method to combine target volume data from 3D and 4D planned thoracic radiotherapy patient cohorts for machine learning applications.

scientific article published on 6 December 2017

A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC)

A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy.

scientific article published on 14 October 2017

A re-audit of patient selection and mortality rates after palliative radiotherapy (PRT) in patients with non-small cell lung cancer (NSCLC)

Abstracts from the 2011 BNOS Conference, June 29 - July 1, 2011, Homerton College, Cambridge

article by S. Ammoun et al published 21 September 2011 in Neuro-Oncology

Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study

scientific article published on 29 January 2019

Advanced Radiotherapy Technologies Network in the UK (ART-NET) – focus on lung cancer ⬇️

article by S. Brown et al published January 2018 in Lung Cancer

Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer

scientific article published on 12 April 2017

An Examination of the Recruitment of Patients to NCRN (National Cancer Research Network) Lung Cancer Radiotherapy Trials at The Christie

An Isotoxic Planning Comparison Study for Stage II–III Non-small Cell Lung Cancer: Is Intensity-modulated Radiotherapy the Answer?

scientific article published on 03 May 2014

An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases to QUARTZ and TACTIC clinical trials in a UK cancer centre

Are We Ready to Safely Combine Anti-PD-1/PD-L1 with Cranial Irradiation in Non-Small Cell Lung Cancer Patients?

scientific article published in April 2018

Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial.

scientific article published on 6 December 2018

Author's Reply to the: Letter to the Editor

scientific article published on 01 April 2019

Automated gross tumour volume contour generation for large-scale analysis of early stage lung cancer patients planned with 4D-CT

scientific article published on 08 December 2020

Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie.

scientific article published on 21 September 2013

BTS guideline for the investigation and management of malignant pleural mesothelioma.

scientific article published on 14 February 2018

Benefit of using motion compensated reconstructions for reducing inter-observer and intra-observer contouring variation for organs at risk in lung cancer patients

scientific article

Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies

scientific article published on 22 June 2016

Breaking the Glass Ceiling for Women in Academic Clinical Oncology in the UK: A Personal View

scientific article published on 14 October 2016

British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.

scientific article published in March 2018

CONVERT – the Challenges of Opening a Multi-centre Radiotherapy Trial in the UK

CONVERT: Concurrent ONce-daily VErsus twice-daily RadioTherapy. A new phase III randomised controlled trial for patients LS SCLC and good performance status

article by Corinne Faivre-Finn & H. Flight published April 2008 in Lung Cancer

CONVERT: Concurrent once-daily versus twice-daily radiotherapy A phase III randomised controlled trial for patients with limited stage small cell lung cancer and good performance status

article by Corinne Faivre-Finn published January 2010 in Lung Cancer

CONVERT: Concurrent once-daily versus twice-daily radiotherapy – a new phase III randomised controlled trial for patients with limited-stage small cell lung cancer and good performance status

article by Corinne Faivre-Finn & S. Falk published January 2009 in Lung Cancer

CONVERTed or not: what are the barriers to implementing the evidence? - Author's reply

scientific article published on 31 October 2017

Cancers bronchiques non à petites cellules localement avancés : quelle radiothérapie en 2014 ?

Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?

scientific article published on 13 May 2020

Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging

scientific article published on 11 December 2017

Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK

scientific article published on 28 October 2021

Changes in the practice of adjuvant radiotherapy in resectable rectal cancer within a French well-defined population

article

Chemotherapy for colon cancer in a well-defined French population: is it under- or over-prescribed?

article

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 9

scientific article

Colon cancer in France: evidence for improvement in management and survival

scientific article published on July 2002

Concurrent Chemoradiotherapy for Locally Advanced, Unresectable Non-small Cell Lung Cancer: A UK Survey of Current Practice

scientific article published on 11 May 2012

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial ⬇️

scientific article published on 19 June 2017

Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature

scientific article

Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts

scientific article published on 15 March 2019

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"

scientific article published on 01 May 2019

Could VMAT Provide Advantages in the Treatment of Hypo-fractionated Stereotactic Lung Radiotherapy?

Curative Radiotherapy for Non-small Cell Lung Cancer: Practice Changing and Changing Practice?

scientific article published on 26 August 2019

Current Practice of Whole Brain Radiotherapy in Metastatic Non-small Cell Lung Cancer.

scientific article published on 12 February 2018

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey

scientific article published on 13 August 2019

Data Mining Identifies the Base of the Heart as a Dose-Sensitive Region Affecting Survival in Lung Cancer Patients

Data Mining in Oncology: The ukCAT Project and the Practicalities of Working with Routine Patient Data

scientific article

Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report

scientific article published on 06 August 2019

Determining internal target volume (ITV) for mobile lung tumours: 2-D kilovoltage (kV) fluoroscopy, 3D or 4D cone-beam CT (CBCT)?

Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.

scientific article published on 24 April 2017

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferio

scientific article published on 02 September 2016

Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value

scientific article

Distributed learning on 20 000+ lung cancer patients - The Personal Health Train

scientific article published on 03 January 2020

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey

scientific article published on 20 February 2018

Do we need another randomised controlled trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention?

Dose escalation in lung cancer: have we gone full circle?

scientific article published on 16 January 2015

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease

scientific article published on 28 October 2019

EP-1087: The clinical usefulness of simultaneous cone beam CT scans captured during prostate radiotherapy

scholarly article by P.D. Dickinson et al published March 2013 in Radiotherapy and Oncology

EP-1527: Early results from a clinical trial of visual feedback from dynamic optical surface sensing in lung cancer patients

scholarly article by G. Price et al published April 2015 in Radiotherapy and Oncology

EP-1775: Assessment of organs at risk contour variability within a UK multicentre lung radiotherapy trial (Isotoxic IMRT)

scholarly article by E. Miles et al published 2014 in Radiotherapy and Oncology

EP-1844: Feasibility of generating mid-position CT from 4DCT using commercial deformable registration systems

scholarly article by M. Van Herk et al published April 2016 in Radiotherapy and Oncology

ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe

scientific article published on 20 December 2018

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

scientific article published on July 2009

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

scientific article published on 28 March 2018

Early Report of Intensity Modulated Radiotherapy (IMRT) for Locally Advanced Lung Cancer at The Christie

Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone

scientific article published on 07 February 2014

Effect of accurate heart delineation on cardiac dose during the CONVERT trial

scientific article published on 31 March 2017

Effect of age, period of diagnosis and birth cohort on large bowel cancer incidence in a well-defined French population, 1976–1995

article

Efficacy of positron emission tomography staging for small-cell lung cancer: a systematic review and cost analysis in the Australian setting.

scientific article published in October 2012

Emerging treatment paradigms for brain metastasis in non-small-cell lung cancer: an overview of the current landscape and challenges ahead

scientific article published on 17 October 2017

Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]

scientific article published on 01 December 2019

European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer

scientific article

European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer

scientific article published on 27 June 2017

European Respiratory Society Guideline on various aspects of quality in lung cancer care

scientific article published on 17 November 2022

Evaluation of innovation in radiation oncology: R-IDEAL

article

Expert knowledge and data-driven Bayesian Networks to predict post-RT dyspnea and 2-year survival

scholarly article by T.M. Deist et al published February 2016 in Radiotherapy and Oncology

Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited-stage small cell lung cancer (LS-SCLC)

article

Guidelines on the radical management of patients with lung cancer

scientific article published on 01 October 2010

High-dose re-irradiation following radical radiotherapy for non-small-cell lung cancer

scientific article

How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?

scientific article published on December 2013

Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer

scientific article published on April 2014

Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy

Imaging biomarker roadmap for cancer studies ⬇️

scientific article

Immune Checkpoint Inhibitors in Lung Cancer - An Unheralded Opportunity?

scientific article published on 4 January 2017

Impact of Integration of Fused FDG-PET and CT Information for GTV Delineation

Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy

scientific article published on 14 April 2020

Implementation of stereotactic body radiotherapy (SBRT) for non small cell lung cancers in the UK

Improving Survival with Thoracic Radiotherapy in Patients with Small Cell Lung Cancer. The CONVERT and the REST Trials

Improving care for patients with lung cancer in the UK.

scientific article published in December 2013

In Regard to Koshy et al

scientific article published on 01 July 2015

In Regard to Zhang et al

scientific article published on 01 August 2019

Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy

scientific article published on 09 May 2019

Intensity-modulated radiotherapy for lung cancer: current status and future developments

scientific article

Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer

scientific article published on 04 July 2019

Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?

scientific article

International Multicenter Randomized Study on Thoracic Radiation Therapy (RT) in Extensive Stage Small Cell Lung Cancer (ES-SCLC): Patterns of Disease Recurrence

Introducing magnetic resonance imaging into the lung cancer radiotherapy workflow - An assessment of patient experience

scientific article published on 22 May 2020

Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET). ⬇️

scientific article published on 11 August 2017

Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer

scientific article published on 5 August 2014

Is heterogeneity in stage 3 non-small cell lung cancer obscuring the potential benefits of dose-escalated concurrent chemo-radiotherapy in clinical trials?

scientific article published on 14 February 2018

Is it time to convert the frequency of radiotherapy in small-cell lung cancer? - Authors' reply

scientific article

Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer

scientific article

Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?

scientific article

Is tumour sphericity an important prognostic factor in patients with lung cancer?

scientific article published on 28 August 2019

Letter to the Editor: Increasing PET Use in Small Cell Lung Cancer

scientific article published on 01 August 2019

Lung cancer after treatment for breast cancer

scientific article published on 10 June 2010

Lung function evaluation before surgery in lung cancer patients: how are recent advances put into practice? A survey among members of the European Society of Thoracic Surgeons (ESTS) and of the Thoracic Oncology Section of the European Respiratory So

LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective

scientific article

Magnetic Resonance Imaging–Guided Radiation Therapy: A Short Strengths, Weaknesses, Opportunities, and Threats Analysis

scientific article published on 01 August 2018

Magnetic resonance imaging in precision radiation therapy for lung cancer

scientific article published in December 2017

Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.

scientific article published on 16 March 2014

Management of small cell lung cancer: recent developments for optimal care

scientific article published on March 2012

Management of small-cell lung cancer

scientific article

Management of stage I and II nonsmall cell lung cancer

scientific article published on 3 January 2017

Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment

scientific article published on March 2008

Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)

scientific article published on 01 April 2010

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 01 October 2018

Modern management of small-cell lung cancer

scientific article published on January 2007

Multi-centre analysis of cardiac events following radical radiotherapy for lung cancer

scientific article published on 01 April 2019

Multifactorial risk factors for mortality after chemotherapy and radiotherapy for non-small cell lung cancer

scientific article published on 20 September 2019

New radiotherapy approaches in locally advanced non-small cell lung cancer

scientific article published on 12 December 2013

O-153 Phase III randomised trial of doxorubicin based chemotherapy compared with platinum based chemotherapy in both limited and extensive stage patients

OC-0140: Management of patients with extensive-stage small-cell lung cancer: A European survey of practice

scholarly article by K. Haslett et al published April 2016 in Radiotherapy and Oncology

OC-0257: A Bayesian network model for acute dysphagia prediction in the clinic for NSCLC patients

scholarly article by A.T.C. Jochems et al published April 2016 in Radiotherapy and Oncology

Omitting elective nodal irradiation (ENI) during thoracic irradiation in limited-stage small cell lung cancer (LS-SCLC) Patterns of failure from a phase II trial

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial

scientific article published on 19 October 2011

Optimal Planning and Delivery of Radiotherapy for Oesophago-gastric Junction (OGJ) Cancers

Optimising recruitment rates to radiotherapy clinical trials for patients with non-small cell lung cancer and brain metastases

scientific article published in September 2010

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, Stage III non-small-cell lung cancer in the PACIFIC trial

scientific article published on 21 March 2020

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

scientific article published on 25 September 2018

Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer

scientific article published on 03 May 2019

PIT. A phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

PO-0656: Effect of accurate heart outlining on radiation dose to the heart - the CONVERT Trial experience

scholarly article by N. Groom et al published April 2015 in Radiotherapy and Oncology

PO-0658: Quality assurance programme for the isotoxic intensity modulated radiotherapy feasibility study

scholarly article by N. Groom et al published April 2015 in Radiotherapy and Oncology

PO-0660: A survey of current lung radiotherapy treatment techniques used during the CONVERT Trial

scholarly article by E. Wilson et al published April 2015 in Radiotherapy and Oncology

PO-0663: Lung V5 does not predict for lung toxicity after fixed-beam intensity modulated radiotherapy (IMRT) for lung cancer

article

PO-0688: Concurrent CTRT (cCTRT) for locally advanced NSCLC followed by consolidation pemetrexed: a phase II study

scholarly article by Corinne Faivre-Finn et al published 2014 in Radiotherapy and Oncology

PO-0724: Comparison of volume delineation on simultaneous and standard cone beam CT images during arc radiotherapy (SCART)

scholarly article by S. Mayes et al published March 2013 in Radiotherapy and Oncology

PO-0744 IS 14 DAY MORTALITY A USEFUL MEASURE OF PALLIATIVE RADIOTHERAPY EFFICACY IN LUNG CANCER

scholarly article by K. Gupta et al published May 2012 in Radiotherapy and Oncology

PO-0788: Predicted patient demand for MRI Linac

scholarly article by B. Sanderson et al published April 2016 in Radiotherapy and Oncology

PO-0961 ISOTOXIC RADIOTHERAPY FOR NON-SMALL CELL LUNG CANCER: IS IMRT THE ANSWER?

scholarly article by M. Warren et al published May 2012 in Radiotherapy and Oncology

PO-0985: How accurate is lung IMRT and VMAT delivery? A multicentre audit as part of the Isotoxic IMRT trial

scholarly article by D.J. Eaton et al published April 2015 in Radiotherapy and Oncology

PO-0988: Evaluation of set up margins and a correction protocol in radical radiotherapy for lung cancer

scholarly article by L. Minchell et al published 2014 in Radiotherapy and Oncology

PO-1119 Suitability of lung margins following analysis of set up data within a multi-national lung trial

scholarly article by M. Bewley et al published April 2015 in Radiotherapy and Oncology

Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC)

scientific article published on 01 April 2019

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

scientific article published on August 2008

Platinum-based chemotherapy with thoracic radiotherapy in stage III good performance status non-small cell lung cancer patients

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)

scientific article published on 01 February 2019

Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy

scientific article published on 20 March 2019

Postoperative Radiotherapy for Pathologic N2 Non–Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: Need for Randomized Evidence

scientific article published on 27 July 2015

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

scientific article published on 06 April 2020

Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? ⬇️

scientific article published on 31 July 2018

Prevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC)

scientific article published on 01 April 2019

Prevention of skin metastasis in malignant mesothelioma with prophylactic irradiation of tracts (PIT): Is the difference in research evidence due to the discrepancy between distance from pleural entry point and the skin scar?

Prise en charge du cancer bronchique à petites cellules (CPC) (localisé et étendu)

Profiling of Circulating Free DNA Using Targeted and Genome-wide Sequencing in Patients with SCLC

scientific article published on 16 October 2019

Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial

scientific article published on 01 July 2019

Prophylactic Cranial Irradiation (PCI) in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (EORTC 22993-08993)

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

scientific article published on 28 March 2019

Prophylactic cranial irradiation (PCI) in extensive disease (ED) small cell lung cancer (SCLC): an audit of practice

Prophylactic cranial irradiation for limited-stage small-cell lung cancer patients: secondary findings from the prospective randomized phase 3 CONVERT trial

article

Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology a

article

Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts

scientific article published on 31 January 2019

Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice

scientific article published on 23 July 2009

Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

scientific article published on 27 January 2016

Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with lim

scientific article published on 20 January 2016

Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study.

scientific article published on 15 April 2016

Quality of life in patients receiving optimal supportive care (including dexamethasone) plus whole-brain radiotherapy in the treatment of inoperable brain metastases from non-small cell lung cancer: The MRC QUARTZ randomised trial

Quantitative evaluation of 4D Cone beam CT scans with reduced scan time in lung cancer patients

scientific article published on 11 April 2019

R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology

scientific article published on 03 April 2017

RADAR Radiation damage and resistance in patients with lung cancer

Radiation dose effect in locally advanced non-small cell lung cancer

scientific article

Radiation dose to heart base linked with poorer survival in lung cancer patients.

scientific article published on 9 September 2017

Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer

scientific article published on 4 June 2012

Radical treatment of non-small cell lung cancer during the last 5 years

scientific article published on 23 January 2013

Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype

scientific article published on 02 June 2020

Radiotherapy Research Trials in the UK: Secrets of Success

scientific article published on 29 February 2012

Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms

scientific article

Radiotherapy for extensive stage small-cell lung cancer - Authors' reply.

scientific article published in April 2015

Radiotherapy for lung cancer in the elderly

scientific article published on 15 January 2010

Radiotherapy for small-cell lung cancer-Where are we heading?

scientific article published on 03 August 2008

Radiotherapy in Extensive-disease Small Cell Lung Cancer. A Survey of Current UK Practice

Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group

scientific article

Randomized trial of erlotinib plus whole-brain radiotherapy for NSCLC patients with multiple brain metastases

scientific article

Re: Small Cell Lung Cancer Treated in Southeast Wales, Lester et al., Clin Oncol 2006;18:378–382

scientific article published on 01 November 2006

Reactive Plan Adaptation for Lung Radiotherapy Based on Cone Beam CT —The Christie Experience

Recent developments in limited stage small cell lung cancer

scientific article published on 01 September 2019

Rechutes locales et métastases à distance après radiochirurgie conservatrice pour cancers du sein de petit volume

Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer

scientific article published on 01 January 2020

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic

scientific article published on 13 May 2020

Reply to G. Zalcman et al

scientific article published on 22 August 2019

Reply to: Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence

article

Residual Setup Errors Towards the Heart After Image Guidance Linked With Poorer Survival in Lung Cancer Patients: Do We Need Stricter IGRT Protocols?

scientific article published on 01 June 2018

Respiratory Intrafraction Motion is an Important Source of Error in Radiotherapy to Oesophago-gastric Junction (OGJ) Cancers

Response on Behalf of the UK Stereotactic Body Radiotherapy Consortium to Brock et al. Clin Oncol (R Coll Radiol) 2008;20(9):666–676

scientific article published on 29 August 2009

Response to a Request for Clarification Regarding the Advanced Radiotherapy Technologies Network (ART-NET)

scientific article published on 02 March 2018

Results from a clinical trial evaluating the efficacy of real-time body surface visual feedback in reducing patient motion during lung cancer radiotherapy

scientific article published on 07 August 2017

SP-0203: Dose / fractionation / IMRT / Imaging

scholarly article by Corinne Faivre-Finn published April 2015 in Radiotherapy and Oncology

SP-0407 CURRENT PRACTICE AND MOVING POINTS: LUNG

scholarly article by Corinne Faivre-Finn published May 2012 in Radiotherapy and Oncology

SP-0617: IMRT for lung cancer: current status and futuredevelopments

scholarly article by Corinne Faivre-Finn published April 2016 in Radiotherapy and Oncology

Scientific Advances in Thoracic Oncology 2016.

scientific article published on 27 May 2017

Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer

scientific article

Short Communication: Management of patients with extensive-stage small-cell lung cancer treated with radiotherapy: A survey of practice

scientific article published on 30 August 2018

Small Cell Lung Cancer (SCLC); any progress?

Stage III non small cell lung cancer: What is evidence based for older patients?

article

Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): Solid evidence or “no-go”?

scientific article published on 07 September 2013

Stereotactic body radiotherapy for central lung tumours: Author reply.

scientific article published on 7 July 2015

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung c

scientific article published on 17 April 2018

Survival of Patients with Non-small Cell Lung Cancer and Brain Metastases

scientific article published on 09 March 2011

Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy

scientific article published on 22 December 2011

Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome

scientific article

The CONVERT Trial: Interpretation, Journey and Lessons Learnt

scientific article published on 18 September 2017

The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer.

scientific article

The Current Role of Radiotherapy in the Treatment of Small Cell Lung Cancer

scientific article published on 10 August 2016

The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer

scientific article published on 27 May 2009

The European initiative for quality management in lung cancer care.

scientific article published on 23 March 2014

The Future of Image-guided Radiotherapy.

scientific article published on 13 May 2017

The UK at the Forefront of Innovative Drug-Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform

scientific article published on 24 February 2020

The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)

scientific article published on 13 October 2018

The advanced radiotherapy network (ART-NET) UK lung stereotactic ablative radiotherapy survey: national provision and a focus on image guidance

scientific article published on 24 April 2019

The clinical utility of circulating tumour cells in patients with small cell lung cancer

scientific article published on August 2017

The evolving role of radiotherapy in non-small cell lung cancer

scientific article published on 19 September 2019

The impact of baseline shifts towards the heart after image guidance on survival in lung SABR patients

scientific article published on 15 November 2019

The largest UK single centre series using hypofractionated radical radiotherapy for NSCLC in the very elderly

scientific article published on 02 May 2013

The role of positron emission tomography in management of small cell lung cancer

scientific article published on 27 April 2011

The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts

scientific article published on 27 December 2019

Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions

scientific article

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC-Update from PACIFIC

scientific article published on 14 October 2019

Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published in September 2015

Time to Change the Limited-Stage Paradigm for Small Cell Lung Cancer?-In Reply

scientific article published on 20 June 2019

Traditional phase 1 and 2 studies in thoracic radiation oncology should be abandoned

scientific article published on 26 September 2014

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts

scientific article published on 20 April 2020

Treatment of limited small cell lung cancer: an old or new challenge? ⬇️

scientific article published on March 1, 2011

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial

scientific article

Using the Malthus programme to predict the recruitment of patients to MR-linac research trials in prostate and lung cancer.

scientific article published on 7 December 2016

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial

scientific article published on 21 March 2017

Whole brain radiotherapy for non-small cell lung cancer - Authors' reply

scientific article published in April 2017

[Prophylactic cranial irradiation in patients with extensive disease caused by small-cell lung cancer responsive to chemotherapy: fewer symptomatic brain metastases and improved survival]

scientific article published on 01 April 2008

Paulina is supported by:

About Paulina

Help